Endava is trading at $1.54, with a -10.47% change, as the selloff extends after its October 28 announcement that it will restate fiscal 2026 results.
- The company said some customer-supplier agreements were incorrectly accounted for.
- Revenue adjustments are estimated at the equivalent of 2%–4% of fiscal 2025 revenue.
- Endava said several previously reported periods should no longer be relied upon; broader technology-sector weakness may add pressure, though the restatement is the clearest company-specific catalyst.